DA-13-007 Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Face; Atrophy
Interventions
DEVICE

DA-13-007 right with left side Sculptra left side

The treatment phase will consist of one to three visits at 3 week intervals during which eligible subjects will receive bilateral injections of study material in the left and right nasolabial fold wrinkles, including visits at weeks 3 and 6 for touch ups if needed

DEVICE

DA-13-007 left with left side Sculptra right side

The treatment phase will consist of one to three visits at 3 week intervals during which eligible subjects will receive bilateral injections of study material in the left and right nasolabial fold wrinkles, including visits at weeks 3 and 6 for touch ups if needed

Trial Locations (4)

33146

Miami Skin Institute, Coral Gables

34209

Bay Area Dermatology, Bradenton

46032

Laser & Skin Surgery Center of Indiana, Carmel

99202

PCR, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DermAvance

INDUSTRY

NCT02310490 - DA-13-007 Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles | Biotech Hunter | Biotech Hunter